Literature DB >> 19092569

Management of anaphylaxis in children.

Danica B Liberman1, Stephen J Teach.   

Abstract

Anaphylaxis is a severe, life-threatening immunoglobulin E (IgE)-mediated hypersensitivity reaction. The key to successful management of anaphylaxis involves rapid diagnosis, assessment, and early initiation of therapy. Epinephrine is the undisputed initial therapy for anaphylaxis, and its administration should never be delayed. In most cases, additional interventions such as oxygen therapy, fluid resuscitation, beta-agonists, antihistamines, and corticosteroids should be strongly considered. Although hospital course must be individualized to meet each patient's needs, a minimum of 4 to 6 hours of observation period after complete symptom resolution may be reasonable to monitor for recurrence of symptoms and biphasic reaction. Before discharge, every patient should receive patient education about anaphylaxis, a prescription for self-injectable epinephrine, and instructions for follow-up care.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19092569     DOI: 10.1097/PEC.0b013e31818ea116

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  6 in total

1.  [Not Available].

Authors:  A Cheng
Journal:  Paediatr Child Health       Date:  2011-01       Impact factor: 2.253

2.  An electronic tongue: evaluation of the masking efficacy of sweetening and/or flavoring agents on the bitter taste of epinephrine.

Authors:  Ousama Rachid; F Estelle R Simons; Mutasem Rawas-Qalaji; Keith J Simons
Journal:  AAPS PharmSciTech       Date:  2010-03-30       Impact factor: 3.246

3.  Emergency treatment of anaphylaxis in infants and children.

Authors:  A Cheng
Journal:  Paediatr Child Health       Date:  2011-01       Impact factor: 2.253

4.  Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel.

Authors:  Joshua A Boyce; Amal Assa'ad; A Wesley Burks; Stacie M Jones; Hugh A Sampson; Robert A Wood; Marshall Plaut; Susan F Cooper; Matthew J Fenton; S Hasan Arshad; Sami L Bahna; Lisa A Beck; Carol Byrd-Bredbenner; Carlos A Camargo; Lawrence Eichenfield; Glenn T Furuta; Jon M Hanifin; Carol Jones; Monica Kraft; Bruce D Levy; Phil Lieberman; Stefano Luccioli; Kathleen M McCall; Lynda C Schneider; Ronald A Simon; F Estelle R Simons; Stephen J Teach; Barbara P Yawn; Julie M Schwaninger
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

5.  Acute treatment of anaphylaxis in children.

Authors:  Ran D Goldman
Journal:  Can Fam Physician       Date:  2013-07       Impact factor: 3.275

Review 6.  Anaphylaxis in children: current understanding and key issues in diagnosis and treatment.

Authors:  Chitra Dinakar
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.